SecBot SecBot
PRESS-RELEASE ·Filed Nov 16, 2026

ACRV

Acrivon Therapeutics, Inc
NEUTRAL
Impact 4/10
Processed8h 51m ago Wirepress-3404102
Press release · Earnings

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3404102

Track record

8 reports on ACRV

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today Press Release Neutral 4/10 Viewing Entry $1.45 Now $1.46 +0.69% settles Feb 16
  2. Nov 10, 20266d ago 8-K Neutral 4/10 Entry $1.57 Now $1.46 −7.01% settles Feb 9
  3. Nov 6, 202610d ago 8-K Neutral 5/10 Entry $1.61 Now $1.46 −9.32% settles Feb 4
  4. Nov 6, 202610d ago Press Release Neutral 4/10 Entry $1.61 Now $1.46 −9.32% settles Feb 4
  5. Jul 21, 202616w ago Press Release Neutral 3/10 Entry $1.68 to $1.76 Now $1.46 −13.10% ▲ +4.76% +1.50% vs SPY
  6. May 22, 202625w ago DEFA14A Neutral 3/10 Entry $1.67 to $2.39 Now $1.46 −12.57% ▲ +43.11% +40.39% vs SPY
  7. Apr 30, 202628w ago DEFA14A Neutral 2/10 Entry $1.85 to $1.56 Now $1.46 −21.08% ▼ −15.68% −18.78% vs SPY
  8. Mar 19, 202634w ago Press Release Bullish 8/10 Entry $1.70 to $1.52 Now $1.46 −14.12% ▼ −10.59% −24.93% vs SPY
Showing 8 of 8

US Market Status

Market Closed · Opens in 8h 32m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 16, 2026

Fresh ACRV Intelligence

Analysis is for subscribers only.

Subscribe for Full Access